drugset / Trial / NCT01639703
Hepatic Xenetix-CT Perfusion
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to prospectively determine the diagnostic value of Xenetix-CT perfusion for the discrimination between well-differentiated hepatocellular carcinomas (HCC) and poorly/moderately differentiated HCC, in histo-pathologically proven HCC, and with the aim to cover the entire liver.
Timeline
- Start
- 2012-04
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iobitridol | Diagnostic / imaging agent | 50 ml | — |